TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
INCR

InterCure Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic

5.20$ +2.8% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement INCR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– -75.2% – – – – +628.6% +237.8% +76.9% -8.5% -32.8% +13.1%
– -71.2% – – – – +343.9% +288.8% +81.7% +7.2% -16.7% +13.6%
– -77.2% – – – – +2,061.9% +185.0% +70.2% -32.2% -71.2% +9.8%
– – – – – – -7.8% -21.6% -48.8% -38.6% +6.7% -5.8%
– -36.3% -30.8% -20.1% +776.7% +708.0% -74.2% +121.7% +102.5% -29.9% -2.1% -4.4%
– -47.7% -58.5% -20.1% +776.7% -50.1% +1,338.0% -10.6% +65.9% +40.4% -33.6% -72.9%
– – – -430.8% – – – – +79.6% -182.1% – –
– +89.8% +98.9% +55.4% +60.4% +92.2% -73.2% +855.5% +191.2% +64.9% -14.8% -4.8%
– – – -2,081.4% – – – – +134.0% -239.8% – –
– – – -78.3% -273.2% – – – -99.2% +2,317.2% -746.4% –
– – – -2,081.4% – – – – +855.6% -238.2% – –
– – – – – – – – +125.3% -134.0% – –

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?